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We thank Dr Cavalcante and colleagues for their constructive comments in response to our 
viewpoint on breast reconstruction during the COVID-19 pandemic.1 We welcome discussion of this time-
sensitive issue within the context of a different healthcare system which they base on an electronic survey 
of Brazilian surgeons over a two-month period.  
A common concern is the backlog of patients, who will eventually require reconstruction, and the 
psychological impact of delayed reconstructive procedures – whether for partial or whole breast 
restitution. Restrictions imposed at the start of the pandemic are being gradually eased but re-introduction 
of breast reconstruction is a challenge for healthcare providers at the present time, especially with fears of 
a second wave of infection and other-site cancers still awaiting curative surgery.  
Furthermore, resumption of ‘normal’ practice is arguably more difficult in those units where rates 
of immediate breast reconstruction (IBR) pre-COVID-19 were high; it is noteworthy that overall rates of 
breast reconstruction in Brazil were 29% before the pandemic, a figure that is higher than recorded in the 
UK National Mastectomy and Breast Reconstruction Audit (21%).2 Issuance of COVID-19 specific guidelines 
by the Association of Breast Surgery3 in the UK had a dramatic effect on IBR with only 30% of units 
reporting continuation of this practice during the pandemic (ABS National Audit – preliminary data).  
The questionnaire sent out to 1462 Brazilian surgeons about reconstructive practice during the 
pandemic had a response rate of just over one-third; it is unclear whether this questionnaire addressed 
intentional or actual reconstructive practice during the pandemic with two-thirds (64%) of surgeons 
supporting IBR using predominantly implant-based techniques (permanent or temporary tissue expanders). 
It is reassuring that only 3% of surgeons would advocate complex flap-based reconstructive procedures 
during the active phase of the pandemic and this concurs with our viewpoint.  
Of interest, just over half of Brazilian surgeons were opposed to therapeutic mammoplasty; this 
procedure can avoid complete mastectomy in some patients with larger breasts and hence negate any 
requirement for IBR. Furthermore, the contralateral side could be done at a later date – perhaps after 
breast irradiation as this can disrupt initial symmetry from a simultaneous balancing procedure. We agree 
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with our Brazilian colleagues that reconstructive procedures should be undertaken on a discretionary basis 
related to individual patient needs/preferences, local circumstances and critically operative capacity 
together with the phase of the pandemic.  
We are now witnessing a resurgence of infection in some parts of the world and this will affect 
reconstructive practice if operative capacity becomes restricted once again. We would argue that implant-
based reconstruction should largely be dependent on operative capacity rather than concerns about 
potential complications, prolonged hospital stays and re-admission. Reconstruction with tissue flaps 
(myocutaneous or otherwise) might be acceptable during the recovery phase if resources are adequate in 
terms of staff and facilities. Standard operating procedures should be adopted to streamline patient care 
and pre-emptively document management plans for any complications.  
Remarkably there is no indication of pandemic stage at the time of this electronic survey; South 
America has lagged behind Europe by approximately 1 – 2 months for phase of disease. Moreover, the 
response rate might have been higher with use of the Total Design Method permitting a more 
representative cross-sectional sample.4 Nonetheless, more than 500 surgeons belonging to the Brazilian 
Society of Mastology submitted responses and presumably these were a mixture of plastic and breast 
oncological surgeons.  
We agree with Cavalcante and colleagues that carefully designed strategies are required as we 
move into the next phase of the COVID-19 pandemic. These must minimise the strain on healthcare 
systems, maximise patient safety and provide optimum cancer care. Surgical practice must be dynamic and 
adapt to changing circumstances with close co-operation between breast and plastic surgeons working 
synergistically within a multidisciplinary team. Resumption of reconstructive practice should closely mirror 
national guidelines and exercise due caution to minimise risks of complications whilst addressing clinical 
need and patient expectations. The latter must be realistic with appropriate selection of patients and 
adherence to a fully informed consent process that reflects the additional risks associated with COVID-19.   
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